CCM
HARP

Consonance Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Consonance Capital Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-84,416
Closed -$14M – 39
2020
Q2 		$14M Buy
+84,416
New +$13.2M 0.84% 24

Other funds holding HARP

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Consonance Capital Management's HARP Position: Q3 2020 in Review

Consonance Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2020, closing a stake of 84,416 shares — an estimated $14M sold.

Consonance Capital Management first reported a position in HARP in Q2 2020 and held it in 1 quarter. The position peaked at $14M in Q2 2020. 79 funds tracked by Wall St. Rank hold HARP as of Q3 2020.

  • Consonance Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Consonance Capital Management sold 84,416 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $14M.
  • Consonance Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Consonance Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $14M in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Consonance Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.